MentionFox
Home › Layoffs › IGM Biosciences, Inc.
SEC filings · Form 8-K, Item 2.05

IGM Biosciences, Inc. layoffs and restructuring

Before you join, sell to or invest in IGM Biosciences, Inc.

MentionFox check on IGM Biosciences, Inc.: no red flags found in 4 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/layoffs/igm-biosciences

  • Note: Layoff plan disclosed Mar 2025 (filing)

New since last check: Layoff plan disclosed Mar 2025 (filing, first seen 14 November 2026).

Check IGM Biosciences, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about IGM Biosciences, Inc.?

Every exit or restructuring plan IGM Biosciences, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

As of November 14, 2026, IGM Biosciences, Inc. has reported 4 exit or restructuring plans to the SEC on Form 8-K under Item 2.05, the latest filed on March 6, 2025. No WARN notice under its name is on file in the states covered here (Form 8-K, March 6, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Redmile Group, LLC also filed stake reports on 18 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of IGM Biosciences, Inc.

Free to see. No signup.

People from IGM Biosciences, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the IGM Biosciences, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings4
Latest filing2025-03-06

IGM Biosciences, Inc. reported 4 exit or restructuring plans on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did IGM Biosciences have layoffs in 2025? What its filings say

IGM Biosciences, Inc. (CIK 1496323) reported 4 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K/A filed 2025-03-06

Expected charges

As a result of the 2025 Restructuring, the Company estimates it will incur total restructuring charges between $0.7 million and $2.0 million, consisting of cash expenditures between $4.1 million and $5.4 million for severance and one-time termination costs offset by non-cash compensation and stock-based compensation expense credit of $3.4 million.

Timing

The Company expects to recognize substantially all restructuring charges in the first quarter of 2025.

Form 8-K filed 2025-01-10

This filing reports Item 2.05, and its section states none of employees affected, share of workforce, locations, charges or timing in a single sentence. The full text is in the filing.

Form 8-K/A filed 2024-11-08

Expected charges

As a result of the 2024 Restructuring, the Company estimates it will incur total restructuring charges between $11.7 million and $14.4 million, consisting of cash expenditures between $3.4 million to $5.7 million for severance and one-time termination costs and between $0.1 million to $0.3 million in contract termination and other costs, along with non-cash incentive and stock-based compensation expense between $8.2 million to $8.4 million.

Timing

The Company expects to recognize substantially all restructuring charges in the third quarter of 2024.

Form 8-K filed 2024-10-03

Timing

The Strategic Pivot activities are expected to be substantially complete in the first quarter of 2025.

Also on the record for IGM Biosciences, Inc.

DateRecordFigureOur pageSource
November 13, 2025Stake report, Schedule 13G/A, by Glazer Capital, LLC—5%+ stakesSource
August 18, 2025Stake report, Schedule 13D/A, by Baker Bros. Advisors LP—5%+ stakesSource
August 18, 2025Stake report, Schedule 13D/A, by Topsoe Holding A/S—5%+ stakesSource
August 15, 2025Stake report, Schedule 13D/A, by Redmile Group, LLC—5%+ stakesSource
July 9, 2025Stake report, Schedule 13G, by Glazer Capital, LLC7.3% of the class5%+ stakesSource

Keep reading

More on IGM Biosciences, Inc. and the records around it.

Companies that share a holder

What do you want to do with IGM Biosciences, Inc.?

Want the whole picture on IGM Biosciences, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on IGM Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on IGM Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    9 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Tools for this story

Each opens in a new tab, filled in for IGM Biosciences, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/igm-biosciences
Last updated 2026-11-14
IGM Biosciences, Inc. layoffs and restructuring: 4 SEC filings (2025-03-06). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/igm-biosciences